Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Colonoscopy | Research article

Elevated serum triglyceride and low-density lipoprotein cholesterol promotes the formation of colorectal polyps

Authors: Chenxi Xie, Pingwu Wen, Jingling Su, Qin Li, Yandan Ren, Yueyu Liu, Renze Shen, Jianlin Ren

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Hyperlipidaemia may be a potential risk factor for the occurrence of intestinal polyps. This study aimed to evaluate correlation between lipidaemia and the formation of colorectal polyps.

Methods

One hundred and fourteen patients with colorectal polyps and forty-eight healthy controls were included in this study. Colonoscopies were performed for all patients and controls within 1 week before blood samples were taken. The concentrations of serum lipids and lipoproteins were measured simultaneously using an automatic biochemical analyser. The colorectal lesions were classified based on pathological characteristics, and four types were identified in the study: hyperplastic polyp (HP), tubular adenoma (TA), tubulovillous adenoma (TVA) and adenoma with high-grade dysplasia (A-HGD). Advanced adenoma was classified according to the number, size and histological type of polyps.

Results

The value of low-density lipoprotein cholesterol (LDL-C) was significantly higher in the group with advanced adenoma than in the controls (p < 0.05). Moreover, the LDL-C values in the HP and TA groups were higher when compared to that of controls (p < 0.05). Obesity, age, and increased TG and LDL-C were independent risk factors for the formation of colorectal polyps. The cut-off values of triglyceride (TG) and LDL-C to distinguish polyp patients from healthy controls were 0.96 mmol/L (AUC = 0.604, p = 0.036) and 3.05 mmol/L (AUC = 0.654, p = 0.002). The combined use of increased LDL-C and TG levels to distinguish polyp patients was effective, with a sensitivity of 50.0% and a specificity of 89.6% (AUC = 0.733, p < 0.01).

Conclusions

Colorectal polyps are more often found in obese and older patients. Increased LDL-C and TG were correlated with the occurrence of polyps. Combination of the two serum indicators was useful to assess risk of colorectal lesions, maybe more effective in screening hyperplastic polyp, tubular adenoma and advanced adenoma.
Literature
1.
go back to reference Dube C, Yakubu M, McCurdy BR, et al. Risk of advanced adenoma, colorectal cancer, and colorectal cancer mortality in people with low-risk adenomas at baseline colonoscopy: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112:1790–801.CrossRef Dube C, Yakubu M, McCurdy BR, et al. Risk of advanced adenoma, colorectal cancer, and colorectal cancer mortality in people with low-risk adenomas at baseline colonoscopy: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112:1790–801.CrossRef
2.
go back to reference Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–62.CrossRef Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658–62.CrossRef
3.
go back to reference Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses aft er colonoscopic polypectomy. Gastroenterology. 2009;136:832–41.CrossRef Martinez ME, Baron JA, Lieberman DA, et al. A pooled analysis of advanced colorectal neoplasia diagnoses aft er colonoscopic polypectomy. Gastroenterology. 2009;136:832–41.CrossRef
4.
go back to reference Ladabaum U, Schoen RE. Post-polypectomy surveillance that would please goldilocks—not too much, not too little, but just right. Gastroenterology. 2016;150:791–6.CrossRef Ladabaum U, Schoen RE. Post-polypectomy surveillance that would please goldilocks—not too much, not too little, but just right. Gastroenterology. 2016;150:791–6.CrossRef
5.
go back to reference Greuter M, de Klerk CM, Meijer GA, Dekker E, Coupe V. Screening for colorectal cancer with fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy: a cost-effectiveness analysis. Ann Intern Med. 2017;167:544–54.CrossRef Greuter M, de Klerk CM, Meijer GA, Dekker E, Coupe V. Screening for colorectal cancer with fecal immunochemical testing with and without postpolypectomy surveillance colonoscopy: a cost-effectiveness analysis. Ann Intern Med. 2017;167:544–54.CrossRef
6.
go back to reference Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science. 2010;328:228–31.CrossRef Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science. 2010;328:228–31.CrossRef
7.
go back to reference Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest. 2007;117:3909–21.PubMedPubMedCentral Vijay-Kumar M, Sanders CJ, Taylor RT, et al. Deletion of TLR5 results in spontaneous colitis in mice. J Clin Invest. 2007;117:3909–21.PubMedPubMedCentral
8.
go back to reference Kwon HJ, Kim HJ, Park YS, et al. Body mass index as a predictor of advanced colorectal neoplasia. J Cancer Prev. 2013;18:144–8.CrossRef Kwon HJ, Kim HJ, Park YS, et al. Body mass index as a predictor of advanced colorectal neoplasia. J Cancer Prev. 2013;18:144–8.CrossRef
9.
go back to reference Ozasa K, Ito Y, Suzuki K, et al. Glucose intolerance and colorectal cancer risk in a nested case-control study among Japanese people. J Epidemiol. 2005;15(Suppl 2):S180–4.CrossRef Ozasa K, Ito Y, Suzuki K, et al. Glucose intolerance and colorectal cancer risk in a nested case-control study among Japanese people. J Epidemiol. 2005;15(Suppl 2):S180–4.CrossRef
10.
go back to reference Suchanek S, Grega T, Ngo O, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22:8103–11.CrossRef Suchanek S, Grega T, Ngo O, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol. 2016;22:8103–11.CrossRef
11.
go back to reference Melvin JC, Holmberg L, Rohrmann S, Loda M, Van Hemelrijck M. Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses. J Cancer Epidemiol. 2013;2013:823849.CrossRef Melvin JC, Holmberg L, Rohrmann S, Loda M, Van Hemelrijck M. Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses. J Cancer Epidemiol. 2013;2013:823849.CrossRef
12.
go back to reference Esposito K, Chiodini P, Capuano A, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine. 2013;44:634–47.CrossRef Esposito K, Chiodini P, Capuano A, et al. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Endocrine. 2013;44:634–47.CrossRef
13.
go back to reference Yang MH, Rampal S, Sung J, et al. The association of serum lipids with colorectal adenomas. Am J Gastroenterol. 2013;108:833–41.CrossRef Yang MH, Rampal S, Sung J, et al. The association of serum lipids with colorectal adenomas. Am J Gastroenterol. 2013;108:833–41.CrossRef
14.
go back to reference Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24:16–31.CrossRef Esteve E, Ricart W, Fernandez-Real JM. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr. 2005;24:16–31.CrossRef
15.
go back to reference van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European prospective investigation into Cancer and nutrition. Gut. 2011;60:1094–102.CrossRef van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European prospective investigation into Cancer and nutrition. Gut. 2011;60:1094–102.CrossRef
16.
go back to reference Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal Cancer. Gastroenterology. 2012;143:844–57.CrossRef Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US multi-society task force on colorectal Cancer. Gastroenterology. 2012;143:844–57.CrossRef
17.
go back to reference Tsilidis KK, Brancati FL, Pollak MN, et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control. 2010;21:1–10.CrossRef Tsilidis KK, Brancati FL, Pollak MN, et al. Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control. 2010;21:1–10.CrossRef
18.
go back to reference Kim NH, Suh JY, Park JH, et al. Parameters of glucose and lipid metabolism affect the occurrence of colorectal adenomas detected by surveillance colonoscopies. Yonsei Med J. 2017;58:347–54.CrossRef Kim NH, Suh JY, Park JH, et al. Parameters of glucose and lipid metabolism affect the occurrence of colorectal adenomas detected by surveillance colonoscopies. Yonsei Med J. 2017;58:347–54.CrossRef
19.
go back to reference Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol. 2006;169:1505–22.CrossRef Cowey S, Hardy RW. The metabolic syndrome: a high-risk state for cancer? Am J Pathol. 2006;169:1505–22.CrossRef
21.
go back to reference Ishino K, Mutoh M, Totsuka Y, Nakagama H. Metabolic syndrome: a novel high-risk state for colorectal cancer. Cancer Lett. 2013;334(1):56–61.CrossRef Ishino K, Mutoh M, Totsuka Y, Nakagama H. Metabolic syndrome: a novel high-risk state for colorectal cancer. Cancer Lett. 2013;334(1):56–61.CrossRef
22.
go back to reference Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266:37–56.CrossRef Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 2004;266:37–56.CrossRef
23.
go back to reference Stocks T, Lukanova A, Bjorge T, et al. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (me-can). Cancer. 2011;117:2398–407.CrossRef Stocks T, Lukanova A, Bjorge T, et al. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (me-can). Cancer. 2011;117:2398–407.CrossRef
24.
go back to reference Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis. 2006;38(9):668–72.CrossRef Chung YW, Han DS, Park YK, et al. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis. 2006;38(9):668–72.CrossRef
25.
go back to reference Liu CS, Hsu HS, Li CI, et al. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol. 2010;10:51.CrossRef Liu CS, Hsu HS, Li CI, et al. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol. 2010;10:51.CrossRef
26.
go back to reference Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1175–85.CrossRef Okabayashi K, Ashrafian H, Hasegawa H, et al. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. 2012;107:1175–85.CrossRef
27.
go back to reference Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab. 2006;17:328–36.CrossRef Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab. 2006;17:328–36.CrossRef
28.
go back to reference Segnan N, Patnick J, von Karssa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: Publications Office of the European Union; 2010. Segnan N, Patnick J, von Karssa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis. 1st ed. Luxembourg: Publications Office of the European Union; 2010.
29.
go back to reference Wang JY, Li ZT, Zhu YM, Wang WC, Ma Y, Liu YL. Utility of the Asia-Pacific colorectal screening scoring system and the presence of metabolic syndrome components in screening for sporadic colorectal cancer. World J Gastroenterol. 2014;20:11394–9.CrossRef Wang JY, Li ZT, Zhu YM, Wang WC, Ma Y, Liu YL. Utility of the Asia-Pacific colorectal screening scoring system and the presence of metabolic syndrome components in screening for sporadic colorectal cancer. World J Gastroenterol. 2014;20:11394–9.CrossRef
30.
go back to reference Kim TJ, Kim JE, Choi YH, et al. Obesity-related parameters and colorectal adenoma development. J Gastroenterol. 2017;52:1221–9.CrossRef Kim TJ, Kim JE, Choi YH, et al. Obesity-related parameters and colorectal adenoma development. J Gastroenterol. 2017;52:1221–9.CrossRef
31.
go back to reference Park YM, Kim HS, Park JJ, et al. A simple scoring model for advanced colorectal neoplasm in asymptomatic subjects aged 40-49 years. BMC Gastroenterol. 2017;17(1):7.CrossRef Park YM, Kim HS, Park JJ, et al. A simple scoring model for advanced colorectal neoplasm in asymptomatic subjects aged 40-49 years. BMC Gastroenterol. 2017;17(1):7.CrossRef
32.
go back to reference Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12(10):1624–34.CrossRef Ma GK, Ladabaum U. Personalizing colorectal cancer screening: a systematic review of models to predict risk of colorectal neoplasia. Clin Gastroenterol Hepatol. 2014;12(10):1624–34.CrossRef
Metadata
Title
Elevated serum triglyceride and low-density lipoprotein cholesterol promotes the formation of colorectal polyps
Authors
Chenxi Xie
Pingwu Wen
Jingling Su
Qin Li
Yandan Ren
Yueyu Liu
Renze Shen
Jianlin Ren
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Colonoscopy
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1115-9

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue